Reconcile®, a flavoured, chewable tablet that contains fluoxetine hydrochloride, was developed specifically for dogs with separation-related disorders.

Reconcile chewable tablets are licensed as an aid in the treatment of separation-related disorders in dogs manifested by destruction and inappropriate  behaviours (vocalisation and inappropriate defecation and/or urination) and only in combination with behavioural modification techniques.

Reconcile® is a prescription only medication and so must be prescribed by a veterinary surgeon.